MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
News Cincinnati loved in 2025
January 2, 2026
The story of prohibition bootlegger George Remus was among WLWT's favorite segments in 2025. UC Law Professor Christopher Bryant spoke with journalist Lindsay Stone about Remus using a temporary insanity defense during a murder trial.
What to know about this year’s big tax changes
January 2, 2026
Local 12 reported that taxpayers can expect some major changes this tax season. Gary Friedhoff, adjunct instructor at the University of Cincinnati’s Carl H. Lindner College of Business, recently spoke to Local 12 about how to avoid surprises.
Study finds police officers face higher long-term health risks
January 2, 2026
J.C. Barnes, a University of Cincinnati professor, is interviewed by Spectrum News about new research showing that the physical and psychological demands of law enforcement can contribute to earlier deaths.